Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases

BACKGROUND: Patients with immune-mediated rheumatic diseases (IMRDs) are commonly treated with immunosuppressors and prone to infections. Recently introduced mRNA SARS-CoV-2 vaccines have demonstrated extraordinary efficacy across all ages. Immunosuppressed patients were excluded from phase III tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieiro Santos, Cristiana, Calleja Antolin, Sara, Moriano Morales, Clara, Garcia Herrero, Juan, Diez Alvarez, Elvira, Ramos Ortega, Fernando, Ruiz de Morales, Jose G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065768/
https://www.ncbi.nlm.nih.gov/pubmed/34987093
http://dx.doi.org/10.1136/rmdopen-2021-001898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065768/
https://www.ncbi.nlm.nih.gov/pubmed/34987093
http://dx.doi.org/10.1136/rmdopen-2021-001898

Ejemplares similares